5D: Biomaterials-Enhanced Cell Therapy: Beta Cells and Beyond

This symposium will highlight breakthroughs in biomaterials that enhance the feasibility and translational potential of cell therapies. Biomaterials have been developed to modulate cell behavior, protect cells from immune attacks, guide patient-specific cellular activity, and stimulate endogenous cell recruitment. One key focus area will be biomaterials that augment beta cell replacement for type 1 diabetes, but the session welcomes discussions on a wide range of cell therapy applications.